Back to top

Image: Shutterstock

Delta (DAL) Flight Makes Emergency Landing on Engine Issue

Read MoreHide Full Article

Per a Reuters report, Delta Air Lines (DAL - Free Report) made an emergency landing at Salt Lake International Airport on Feb 22 after an engine performance issue cropped up.

Flight DL2123, en route to Seattle, WA from Atlanta, GA, was operating on a Boeing 757-200 aircraft. A Delta spokeswoman reportedly stated that the plane diverted “out of an abundance of caution following an indicator warning of a possible problem with one of its engines.”

She further added that “the flight landed safely without incident and taxied to the gate without assistance” and that Delta, carrying a Zacks Rank #3 (Hold), was working to re-accommodate customers on another flight.

On a similar incident, last weekend, a United Airlines (UAL - Free Report) flight, operating on a Boeing 777 aircraft, made an emergency landing at the Denver International Airport after its right engine failed. Soon after this fiasco, the carrier announced that it was "voluntarily & temporarily" withdrawing the 24 Boeing 777 jets currently in its fleet, from service. The Boeing Company (BA - Free Report) has also recommended the temporary suspension of these jets. Meanwhile, the Federal Aviation Administration stated that it required increased inspections of the Boeing 777 jets. Both United Airlines and Boeing carry a Zacks Rank #4 (Sell).

A Key Pick

A better-ranked stock in the broader Transportation sector is ArcBest Corp. (ARCB - Free Report) carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The ArcBest stock has rallied more than 68% in the last six months.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>